Cancer Chemotherapy and Biological Response Modifiers

Introduction. I. DRUGS. Antimetabolites (P.G. Johnston et al.). Bleomycin (J.S. Lazo, S.M. Sebti). Mitomycins (J. Verweij). Taxanes (D. Sackett, T. Fojo). DNA topoisomerase I inhibitors (Ch.H. Takimoto, L.V. Kieffer, S.G. Arbuck). DNA topoisomerase II poisons and inhibitors (G. Capranico et al.). Cisplatin (E. Reed). Multidrug resistance (J.A. Moscow et al.). New anticancer agents (G.R. Weiss et al.). II. BIOLOGICAL RESPONSE MODIFIERS. Monoclonal antibody therapy of cancer (J.G. Jurcic, D.A. Scheinberg, A.N. Houghton). Cytokines and immunological monitoring (J.A. Sosman, A. Sawhany). Biological response modifiers (J.W. Clark). Adoptive immunotherapy (B.D. Curti). Strategies for cancer gene therapy (G. Dranoff). Retinoids, neoplasma and differentiation therapy (S.M. Lippman, P.J.A. Davies). Hematopoietic growth factors in cancer chemotherapy (G.J. Lieschke, M. Foote, G. Morstyn). III. TUMORS. Leukemias and plasma cell myeloma (P.H. Wiernik). AIDS-related malignancies (M.W. Saville). Head and neck cancer (S.G. Taylor IV). Lung cancer (H.H. Hansen, M. Rorth). Upper gastrointestinal tumors (M. Ogawa, T. Taguchi). Cancers of the large bowel and hepatobiliary tract (D.J. Vaughn, J. Treat). Endocrine tumours (S.W.J. Lamberts) Genitourinary malignancy (N. Haas, G.R. Hudes). Chemotherapy of gynecologic cancers (M.P. Boente, R. Schilder, R.Z. Ozols). Breast cancer (P.P. Carbone, H.H. Bailey, J.A. Stewart). Soft tissue and bone sarcomas (A. Santoro, P. Casali). Brain tumors (E.A.M.T. Obbens, W.R. Shapiro). Biology and treatment of pediatric malignant solid tumors (N.M. Marina). Supportive care (M. Markman). Abbreviations of drugs. Abbreviations of chemotherapeutic combinations. Biological abbreviations. NSC-numbers. Subject index.